News
VRAX
0.1499
-1.06%
-0.0016
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 3d ago
Virax CEO Foster Releases Shareholder Letter Regarding Upcoming Milestones
NASDAQ · 3d ago
Virax Biolabs CEO Sets Near-Term Milestones as ViraxImmune Strategy Advances and Valuation Lags
TipRanks · 3d ago
Virax Biolabs publishes updated Q2 2026 investor presentation and factsheet
PUBT · 3d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 3d ago
Virax Biolabs CEO outlines strategic priorities, near-term milestones
TipRanks · 3d ago
Virax Biolabs announces availability of shareholder letter from CEO James Foster
PUBT · 3d ago
VIRAX BIOLABS' CEO JAMES FOSTER OUTLINES STRATEGIC PRIORITIES AND NEAR-TERM MILESTONES IN LETTER TO SHAREHOLDERS
Reuters · 3d ago
Why Bloom Energy Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 4d ago
Dow Dips Over 350 Points; Goldman Sachs Posts Upbeat Earnings
Benzinga · 4d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 4d ago
Stocks To Watch Today: IDYA, OGN, VRX, REPL...
NASDAQ · 4d ago
Weekly Report: what happened at VRAX last week (0406-0410)?
Weekly Report · 4d ago
Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Benzinga · 4d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 04/10 21:13
Virax Biolabs Announces Full Exercise of Pre-Funded Warrants From $5 Million Private Placement
TipRanks · 04/10 20:57
Virax Biolabs raises $5 million in private placement via pre-funded warrants, options
Reuters · 04/10 20:16
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 04/10 17:05
More
Webull provides a variety of real-time VRAX stock news. You can receive the latest news about Virax Biolabs Group Ltd through multiple platforms. This information may help you make smarter investment decisions.
About VRAX
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).